CDC's Early Response to a Novel Viral Disease, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), September 2012-May 2014
CDC's Early Response to a Novel Viral Disease, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), September 2012-May 2014
复制标题
DOI：
10.1177/003335491513000407
复制
发表时间：
2015-07-01
影响因子：
3.3
通讯作者：
Swerdlow, David L.
中科院分区：
文献类型：
--
作者：
Williams, Holly Ann;Dunville, Richard L.;Swerdlow, David L.
2012 年 9 月报告了首例中东呼吸综合征冠状病毒 (MERS-CoV) 病例。本报告介绍了 CDC 与世界卫生组织 (WHO) 和其他合作伙伴合作应对这种新型病毒所采取的方法，并概述了 2014 年 5 月美国出现第一例病例之前各机构的应对措施。在此期间，CDC 的应对措施综合了多个学科，并分为三个不同的阶段：初始激活之前、期间和之后其紧急行动中心。 CDC 应对中东呼吸综合征冠状病毒需要付出巨大努力，部署了至少 353 名工作人员，负责监测、实验室能力、感染控制指导和旅行者健康等领域的工作。这一应对措施建立在疾病预防控制中心之前处理其他病原体爆发的经验基础上，并为未来出现的威胁提供了有用的经验教训。
The first ever case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was reported in September 2012. This report describes the approaches taken by CDC, in collaboration with the World Health Organization (WHO) and other partners, to respond to this novel virus, and outlines the agency responses prior to the first case appearing in the United States in May 2014. During this time, CDC's response integrated multiple disciplines and was divided into three distinct phases: before, during, and after the initial activation of its Emergency Operations Center. CDC's response to MERS-CoV required a large effort, deploying at least 353 staff members who worked in the areas of surveillance, laboratory capacity, infection control guidance, and travelers' health. This response built on CDC's experience with previous outbreaks of other pathogens and provided useful lessons for future emerging threats.